Market revenue in 2023 | USD 30,592.2 million |
Market revenue in 2030 | USD 74,238.1 million |
Growth rate | 13.5% (CAGR from 2023 to 2030) |
Largest segment | Health |
Fastest growing segment | Bioinformatics |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Health, Food & Agriculture, Natural reseources & Environment, Industrial Processing, Bioinformatics, Others Applications |
Key market players worldwide | AstraZeneca PLC, Gilead Sciences Inc, Bristol-Myers Squibb Co, Sanofi SA, Biogen Inc, Abbott Laboratories, Pfizer Inc, Amgen Inc, Novo Nordisk A/S ADR, Merck KGaA, Johnson & Johnson, Novartis AG ADR, Roche Holding AG, Lonza Group Ltd |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biotechnology market will help companies and investors design strategic landscapes.
Health was the largest segment with a revenue share of 43.96% in 2023. Horizon Databook has segmented the Spain biotechnology market based on health, food & agriculture, natural reseources & environment, industrial processing, bioinformatics, others applications covering the revenue growth of each sub-segment from 2018 to 2030.
According to a report named "AseBio 2019: Ready for the Spain of Tomorrow," Spain ranked 9th in the production of scientific articles associated with biotechnology. This indicates high involvement of the country's scientific community in the biotechnology research. In addition, Spanish government is providing funding to support genomics research in the country.
For instance, in November 2020, the government granted USD 30 million (EUR 25 million) for precision and genomic medicine. Such initiatives are anticipated to boost the market growth in the near future. The Centre for Genomic Regulation, based in Spain, co-ordinates the European Advanced infrastructure for Innovative Genomics project that is funded by research and innovation program Horizon 2020 of the European Union.
This project joins 16 industrial and academic partners to support several genomics projects involving sequencing and bioinformatics analysis. This project represents a lucrative opportunity for research teams to access high-end sequencing services.
Horizon Databook provides a detailed overview of country-level data and insights on the Spain biotechnology market , including forecasts for subscribers. This country databook contains high-level insights into Spain biotechnology market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account